Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

cabozantinib 1 anifrolumab 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Platinum Compounds 1 Nivolumab 1 Methods 1 Ipilimumab 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lupus Erythematosus, Systemic × anifrolumab × 90 days × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡